Vibrio cholerae O1 Ogawa detoxified lipopolysaccharide structures as inducers of cytokines and oxidative species in macrophages

Journal of Medical Microbiology

Volumn 59, Issue 2, 2010, Pages 158-164

  Paulovičová, Ema ^a   Kováčová, Elena ^b   Bystrický, Slavomír ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b Faculty of Natural Sciences   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

3 DEOXY MANNO OCTULOSONIC ACID; ANTIGEN; CHOLERA VACCINE; CYTOKINE; GLYCOLIPID; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DETOXIFICATION; EX VIVO STUDY; IMMUNOMODULATION; MALE; MOUSE; NONHUMAN; OXIDATION; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; VIBRIO CHOLERAE;

ANIMALS; BACTERIAL VACCINES; CELLS, CULTURED; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; MACROPHAGES, PERITONEAL; MALE; MICE; NITRIC OXIDE; O ANTIGENS; REACTIVE OXYGEN SPECIES; VIBRIO CHOLERAE;

EID: 76049094358     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.013599-0     Document Type: Article

References (37)

1. Akagawa, K. S. & Tokumaga, T. (1985). Lack of binding of bacterial lipopolysaccharide to mouse lung macrophages and restoration of binding by interferon gamma. J Exp Med 162, 1444-1459.
2. Alexander, Ch. & Rietschel, E. T. (2001). Bacterial lipopolysaccharides and innate immunity. J Endotoxin Res 7, 167-202.
3. Boutonnier, A., Villeneuve, S., Nato, F., Dassy, B. & Fournier, J. M. (2001). Preparation, immunogenicity, and protective efficacy, in a murine model, of a conjugate vaccine composed of the polysaccharide moiety of the lipopolysaccharide of Vibrio cholerae O139 bound to tetanus toxoid. Infect Immun 69, 3488-3493.
4. Cavaillon, J. M. (1994). Cytokines and macrophages. Biomed Pharmacother 48, 445-453.
5. Cavaillon, J. M., Fitting, C., Caroff, M., Haeffner, C. A. & Vaillon, N. (1989). Dissociation of cell-associated interleukin-1 (IL-1) and IL-1 release induced by lipopolysaccharide and lipid A. Infect Immun 57, 791-797.
6. Chaby, R. (2004). Lipopolysaccharide-binding molecules: transporters, blockers and sensors. Cell Mol Life Sci 61, 1697-1713.
7. Chatterjee, S. N. & Chaudhuri, K. (2003). Lipopolysaccharides of Vibrio cholerae. I. Physical and chemical characterization. Biochim Biophys Acta 1639, 65-79.
8. Chatterjee, S. N. & Chaudhuri, K. (2006). Lipopolysaccharides of Vibrio cholerae. III. Biological functions. Biochim Biophys Acta 1762, 1-16.
9. Chernyak, A., Kondo, S., Wade, T. K., Meeks, M. D., Alzari, P. M., Fournier, J. M., Taylor, R. K., Kovac, P. & Wade, W. F. (2002). Induction of protective immunity by synthetic Vibrio cholerae hexasaccharide derived from Vibrio cholerae O1 Ogawa lipopolysaccharide bound to a carrier protein. J Infect Dis 185, 950-952.
10. Chi, D. S., Qui, M., Krishnaswamy, G., Li, C. H. & Stone, W. (2003). Regulation of nitric oxide production from macrophages by lipopolysaccharide and catecholamines. Nitric Oxide 8, 127-132.
11. Ding, A. H., Nathan, C. F. & Stuehr, D. J. (1988). Release of reactive nitrogen intermediate and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 141, 2407-2412.
12. Dube, P. H., Handley, S. A., Lewis, J. & Miller, V. L. (2004). Prospective role of interleukin-6 during Yersinia enterocolitica infection is mediated through the modulation of inflammatory cytokines. Infect Immun 72, 3561-3570.
13. Erridge, C., Bennett-Guerrero, E. & Poxton, I. R. (2002). Structure and function of lipopolysaccharides. Microbes Infect 4, 837-851.
14. Forman, H. J. & Torres, M. (2002). Reactive oxygen species and cell signaling. Respiratory burst in macrophage signaling. Am J Respir Crit Care Med 166, S4-S8.
15. Gupta, R. K., Szu, S. C., Finkelstein, R. A. & Robbins, J. B. (1992). Synthesis, characterization, and some immunological properties of conjugates composed of the detoxified lipopolysaccharide of Vibrio cholerae O1 serotype Inaba bound to cholera toxin. Infect Immun 60, 3201-3208.
16. Haeffner-Cavaillon, N., Bacle, F., Caroff, M. & Cavaillon, J. M. (1988). Characteristics of lipopolysaccharide-induced interleukin-1 production by human monocytes. Clinical relevance in patients undergoing hemodialysis. Prog Clin Biol Res 272, 89-101.
17. Janeway, C. A., Jr & Medzhitov, R. (1999). Innate immunity: lipoproteins take their Toll on the host. Curr Biol 9, R879-R882.
18. Johnson, A. G. (1994). Molecular adjuvants and immunomodulators: new approaches to immunization. Clin Microbiol Rev 7, 277-289.
19. Koj, A. (1985). Biological functions of acute phase proteins. In The Acute Phase Response to Injury and Infection, pp. 139-144. Edited by A. H. Gordon & A. Koj. Amsterdam: Elsevier.
20. Kondo, S., Zahringer, U., Seydel, U., Sinnwell, V., Hisatsune, K. & Rietschel, E. T. (1991). Chemical structure of the carbohydrate backbone of Vibrio parahaemolyticus serotype 012 lipopolysaccharide. Eur J Biochem 200, 689-698.
21. Kossaczka, Z., Shiloach, J., Johnson, V., Taylor, D. N., Finkelstein, R. A., Robbins, J. B. & Szu, S. C. (2000). Vibrio cholerae O139 conjugate vaccines: synthesis and immunogenicity of Vibrio cholerae O139 capsular polysaccharide conjugates with recombinant diphtheria toxin mutant in mice. Infect Immun 68, 5037-5043.
22. Lebbar, S., Cavaillon, J. M., Caroff, M., Ledur, A., Brade, H., Sarfati, R. & Haeffner-Cavaillon, N. (1986). Molecular requirement for interleukin 1 induction by lipopolysaccharide-stimulated human monocytes: involvement of heptosyl-2-keto-deoxyoctulosonate region. Eur J Immunol 16, 87-91.
23. Mosser, D. M. & Zhang, X. (2008). Activation of murine macrophages Current Protoc Immunol 83, 14.2.1-14.2.8.
24. Opal, S. M. & dePalo, V. A. (2000). Anti-inflammatory cytokines. Chest 117, 1162-1172.
25. Otterlei, M., Sundan, A., Skjak-Braek, G., Ryan, L., Smidsrod, O. & Espevik, T. (1993). Similar mechanisms of action of defined polysaccharides and lipopolysaccharides: characterization of binding and tumor necrosis factor alpha induction. Infect Immun 61, 1917-1925.
26. Park, J. & Rikihisha, Y. (1991). Inhibition of Ehrlichia risticii infection in murine peritoneal macrophages by gamma interferon, a calcium ionophore and concanavalin A. Infect Immun 59, 3418-3423.
27. Paulovičová , E., Machová , E., Hoš tacká , A. & Bystrický , S. (2006). Immunological properties of complex conjugates based on Vibrio cholerae O1 Ogawa lipopolysaccharide antigen. Clin Exp Immunol 144, 521-527.
28. Rabehi, L., Irinopoulou, T., Cholley, N., Haeffner-Cavaillon, N. & Carreno, M. P. (2001). Gram-positive and Gram-negative bacteria do not trigger monocytic cytokine production through similar intracellular pathways. Infect Immun 69, 4590-4599.
29. Rietschel, E. T., Brade, H., Holst, O., Brade, L., Muller-Leonnies, S., Mamat, U., Zahringer, U., Beckman, F., Seydel, U. & other authors (1996). Bacterial endotoxin: chemical constitution, biological recognition, host response, and immunological detoxification. Curr Top Microbiol Immunol 216, 39-81.
30. Roychowdhury, A., Pan, A., Dutta, D., Mukhopadhyay, A. K., Ramamurthy, T., Nandy, R. K. & Bhattacharya, S. K. (2008). Emergence of tetracycline-resistent Vibrio cholerae O1 serotype Inaba in Kolkata, India. Jpn J Infect Dis 61, 128-129.
31. Scheibenbogen, C. & Andreesen, R. (1991). Developmental regulation of the cytokine repertoire in human macrophages: IL-1, IL-6, TNF-α and M-CSF. J Leukoc Biol 50, 35-42.
32. Tanamoto, K., Zähringer, U., McKenzie, G. R., Galanos, C., Rietschel, E. T., Lüderitz, O., Kusumoto, S. & Shiba, T. (1984). Biological activities of synthetic lipid A analogs: pyrogenicity, lethal toxicity, anticomplement activity, and induction of gelation of Limulus amoebocyte lysate. Infect Immun 44, 421-426.
33. Tilg, H., Trehu, E., Atkins, M. B., Dinarello, C. A. & Mier, J. W. (1994). Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor anagonist and soluble tumor necrosis factor receptor p55. Blood 83, 113-118.
34. Viswanathan, V. K., Sharma, R. & Hecht, G. (2004). Microbes and their products - physiological effects upon mammalian mucosa. Adv Drug Deliv Rev 56, 727-762.
35. Waage, A., Brandtzaeg, P., Espevik, T. & Halstensen, A. (1991). Current understanding of the pathogenesis of Gram-negative shock. Infect Dis Clin North Am 5, 781-791.
36. Westphal, O. & Jann, K. (1965). Bacterial lipopolysaccharides. Extraction with phenol-water and further application of the procedure. Methods Carbohydr Res 5, 83-91.
37. Yamamoto, T., Taneike, I., Tamura, Y. & Wakisaka-Saito, N. (2000). Multiple drug resistance of Vibrio cholerae O1 and O139 isolated from various regions of the world: changes in the past 10 years. Acta Med Biol 48, 75-88.